Indication for Class 2
Cranial Electrotherapy Stimulation is indicated for the treatment of depression, anxiety and insomnia in adult substance abuse patients who have failed to achieve satisfactory improvement from one prior antidepressant or sleep medication at or above the minimal effective dose and duration in the current episode, or are unable to tolerate such medication.
Current Indication (Class 3)
Cranial Electrotherapy Stimulation is indicated for the treatment of depression, anxiety and insomnia. • Randomized (1:1) double-blind study of 21 psychiatric inpatients suffering depressive disorders with no active drug treatment during stimulation • Baseline characteristics not significantly different, but point estimates are not close for some variables (age, gender, length of illness) • Two 30 min treatments over 5 days showed significant declines in anxiety and increases in awakening time in CES patients but not in controls during the 5-day withdrawal period (from treatment drugs); and no report of adverse events • No direct comparison of differences from baseline were done or could be done from the data presented Philip et al. Efficiency of transcranial electrostimulation on anxiety and insomnia symptoms during a washout period in depressed patients A double-blind study. Biol. Psychiatry 29: [451] [452] [453] [454] [455] [456] 1991 • Randomized study of 28 former heroin addicts undergoing treatment for methadone withdrawal (14 CET, 7 sham and 7 non-sham controls) • Balance of baseline characteristics not tested, but anxiety scores in same range for all three groups • Ten 30 min sessions over 14 days demonstrated significantly reduced anxiety levels (Taylor) and dramatically reduced methadone intake in the 13 CET subjects remaining in the study but no change in either control group for anxiety levels • Some of the reductions above not supported by P-values • No report of adverse events Gomez, E. and A. Mikhail • Randomized double-blind study of 28 psychiatric outpatients on reduction in symptomatic days and symptom sensitivity • Baseline characteristics were not tested and some appear to be different (age and primary psychiatric diagnosis) • Five daily 30 min treatments showed no statistically significant difference in symptom-free days of on day 5 and 19 after initial treatment . A second variable recording whether symptoms bothered subject was significant in favor of CES on day 5, but not on day 19 • Relevance of endpoints especially long after cessation of treatment is questionable • No report of adverse events Hearst et al. Electrosleep Therapy. Arch. Gen. Psychiatry 30:463-466, 1974 Lack of Effectiveness (Human) 2
Psychiatrists
• Randomized double-blind study of 25 cocaine and 18 opiate dependent male subjects during withdrawal • No analysis of baseline characteristics and patients appear to be on methadone during the trial • Continuous exposure for 7-10 days failed to show statistically significant effect of CES on withdrawal scales, however all sham subjects received low level of current thought to be incapable of producing effect by authors in this study • No reports of adverse events • Authors admit that sham exposure could be therapeutic and that measurement questionnaires may be inadequate to detect changes in withdrawal symptoms in this population -Admitting the limitations of the studies evaluated, human and animal randomized studies show clinically effective and statistically significant changes to some studied conditions in selected populations following electrical stimulation to the head, and -Human studies provide evidence that electrical stimulation of the head produces changes in biochemical components in blood and cerebral spinal fluid that may be associated with the clinical changes found in the randomized studies 
